Filing Details
- Accession Number:
- 0001104659-19-059509
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-04 16:16:35
- Reporting Period:
- 2019-10-31
- Accepted Time:
- 2019-11-04 16:16:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1737953 | Replimune Group Inc. | REPL | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376491 | Philip Astley-Sparke | C/O Replimune Group, Inc. 18 Commerce Way Woburn MA 01801 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-10-31 | 14,500 | $17.00 | 1,413,297 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 was made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
- Following the sale reported on this Form 4, the reporting person continues to beneficially own 1,413,297 shares of the Issuer's common stock. The reporting person also holds options to acquire 382,571 shares of the Issuer's common stock, 94,103 of which are exercisable as of the date hereof.